Hexylresorcinol: Uses, Side Effects, Dosage - Drugvu

ℹ️ Compiled from public regulatory records · Last regulator revision: May 29, 2026🚩 Report this page

Hexylresorcinol

Antiseptics

Sold as STREPSILS ANAESTHETIC… · STREPSILS EXTRA BLACK…

GB MHRACA Health Canada

Drug class: Antiseptics
Availability: See label
Routes: Oral
Markets covered: 2
Products on record: 18

Overview

Hexylresorcinol is an active pharmaceutical ingredient in the Antiseptics group (R02AA). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.

Regulatory status by market

Market	Regulator	Products	Last revision
GB United Kingdom	MHRA	13	May 29, 2026
CA Canada	Health Canada	5	March 18, 2026

GBUnited Kingdom· MHRA

13 products

Uses

GBOfficial regulatory label· revised March 14, 2025[1]

As an antiseptic and local anaesthetic for the relief of sore throat and its associated pain.

How to take

CACanada· Health Canada

5 products

5 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].

Brands in Canada (2)

Sources & citations

[1]MHRA (UK) · PL000630392 · revised March 14, 2025
[2]Health Canada (DPD) · 00895466 · revised March 22, 2025

Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.

Side effects & warnings

GBOfficial regulatory label· Adverse reactions· revised March 14, 2025[1]

System Organ Class Frequency Adverse Events Immune System Disorders Not known Hypersensitivity1 1 Hypersensitivity reactions may include rash, urticaria and angioedema, which may include swelling of the face, neck, throat or tongue that could affect breathing.
Reporting of Suspected Adverse Reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

GBOfficial regulatory label· Warnings and precautions· revised March 14, 2025[1]

The label will convey:
Keep out of the reach and sight of children. If symptoms persist consult your doctor. Not to be given to children under 6 years. Important information about some of the ingredients of this medicine • This medicine contains only very low levels of gluten (from wheat starch).
It is regarded as ‘gluten-free’ and is very unlikely to cause problems if you have coeliac disease. 42 micrograms of gluten. If you have wheat allergy (different from coeliac disease) you should not take this medicine. • This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.
• This medicine contains fragrance with d-Limonene and Linalool. d-Limonene and Linalool may cause allergic reactions. • This medicine contains carmoisine (E122) which may cause allergic reactions • This medicine contains Sulphites – Sulphur Dioxide (E220) – present in liquid glucose which may rarely cause severe hypersensitivity reactions and bronchospasm.
• Patients with rare glucose-galactose malabsorption should not take this medicine • Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

This is not medical advice. Consult a qualified healthcare professional.

Overview

Regulatory status by market

GBUnited Kingdom· MHRA

CACanada· Health Canada

Drugs in the same class

Sources & citations